Usefulness of Two Aspergillus PCR Assays and Aspergillus Galactomannan and β-D-Glucan Testing of Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis

被引:47
作者
Urabe, Naohisa [1 ]
Sakamoto, Susumu [1 ]
Sano, Go [1 ]
Suzuki, Junko [2 ]
Hebisawa, Akira [3 ]
Nakamura, Yasuhiko [1 ]
Koyama, Kazuya [1 ]
Ishii, Yoshikazu [4 ]
Tateda, Kazuhiro [4 ]
Homma, Sakae [1 ]
机构
[1] Toho Univ, Omori Med Ctr, Dept Resp Med, Tokyo, Japan
[2] Natl Hosp Org, Tokyo Natl Hosp, Ctr Pulm Dis, Tokyo, Japan
[3] Natl Hosp Org, Tokyo Natl Hosp, Dept Clin Res, Tokyo, Japan
[4] Toho Univ, Sch Med, Dept Microbiol & Infect Dis, Tokyo, Japan
关键词
chronic pulmonary aspergillosis; Aspergillus galactomannan test; beta-D-glucan test; Aspergillus PCR assays; LINKED-IMMUNOSORBENT-ASSAY; POLYMERASE-CHAIN-REACTION; INVASIVE ASPERGILLOSIS; PLATELIA ASPERGILLUS; IMMUNOCOMPROMISED PATIENTS; CLINICAL CHARACTERISTICS; MULTICENTER TRIAL; CHRONIC CAVITARY; VORICONAZOLE; FUMIGATUS;
D O I
10.1128/JCM.02497-16
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We evaluated the usefulness of an Aspergillus galactomannan (GM) test, a beta-D-glucan (beta DG) test, and two different Aspergillus PCR assays of bronchoalveolar lavage fluid (BALF) samples for the diagnosis of chronic pulmonary aspergillosis (CPA). BALF samples from 30 patients with and 120 patients without CPA were collected. We calculated the sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio for each test individually and in combination with other tests. The optical density index values, as determined by receiver operating characteristic analysis, for the diagnosis of CPA were 0.5 and 100 for GM and beta DG testing of BALF, respectively. The sensitivity and specificity of the GM test, beta DG test, and PCR assays 1 and 2 were 77.8% and 90.0%, 77.8% and 72.5%, 86.7% and 84.2%, and 66.7% and 94.2%, respectively. A comparison of the PCR assays showed that PCR assay 1 had a better sensitivity, a better negative predictive value, and a better negative likelihood ratio and PCR assay 2 had a better specificity, a better positive predictive value, and a better positive likelihood ratio. The combination of the GM and beta DG tests had the highest diagnostic odds ratio. The combination of the GM and beta DG tests on BALF was more useful than any single test for diagnosing CPA.
引用
收藏
页码:1738 / 1746
页数:9
相关论文
共 42 条
[1]   Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature [J].
Agarwal, Ritesh ;
Vishwanath, Gella ;
Aggarwal, Ashutosh N. ;
Garg, Mandeep ;
Gupta, Dheeraj ;
Chakrabarti, Arunaloke .
MYCOSES, 2013, 56 (05) :559-570
[2]   Molecular diagnosis of invasive aspergillosis: the long and winding road [J].
Boudewijns, Michael ;
Verweij, Paul E. ;
Melchers, Willem J. G. .
FUTURE MICROBIOLOGY, 2006, 1 (03) :283-293
[3]   Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction:: Clinical results [J].
Buchheidt, D ;
Baust, C ;
Skladny, H ;
Ritter, J ;
Suedhoff, T ;
Baldus, M ;
Seifarth, W ;
Leib-Moesch, C ;
Hehlmann, R .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (04) :428-435
[4]   Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial [J].
Cadranel, J. ;
Philippe, B. ;
Hennequin, C. ;
Bergeron, A. ;
Bergot, E. ;
Bourdin, A. ;
Cottin, V. ;
Jeanfaivre, T. ;
Godet, C. ;
Pineau, M. ;
Germaud, P. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (11) :3231-3239
[5]   Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients [J].
Camuset, Juliette ;
Nunes, Hilario ;
Dombret, Marie-Christine ;
Bergeron, Anne ;
Henno, Priscilla ;
Philippe, Bruno ;
Dauriat, Gaelle ;
Mangiapan, Gilles ;
Rabbat, Antoine ;
Cadranel, Jacques .
CHEST, 2007, 131 (05) :1435-1441
[6]   Cryptococcus neoformans galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus galactomannan [J].
Dalle, F ;
Charles, PE ;
Blanc, K ;
Caillot, D ;
Chavanet, P ;
Dromer, F ;
Bonnin, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (06) :2929-2931
[7]   Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function? [J].
de Vrankrijker, A. M. M. ;
van der Ent, C. K. ;
van Berkhout, F. T. ;
Stellato, R. K. ;
Willems, R. J. L. ;
Bonten, M. J. M. ;
Wolfs, T. F. W. .
CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (09) :1381-1386
[8]   Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management [J].
Denning, David W. ;
Cadranel, Jacques ;
Beigelman-Aubry, Catherine ;
Ader, Florence ;
Chakrabarti, Arunaloke ;
Blot, Stijn ;
Ullmann, Andrew J. ;
Dimopoulos, George ;
Lange, Christoph .
EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (01) :45-68
[9]   High-frequency Triazole Resistance Found In Nonculturable Aspergillus fumigatus from Lungs of Patients with Chronic Fungal Disease [J].
Denning, David W. ;
Park, Steven ;
Lass-Florl, Cornelia ;
Fraczek, Marcin G. ;
Kirwan, Marie ;
Gore, Robin ;
Smith, Jaclyn ;
Bueid, Ahmed ;
Moore, Caroline B. ;
Bowyer, Paul ;
Perlin, David S. .
CLINICAL INFECTIOUS DISEASES, 2011, 52 (09) :1123-1129
[10]   Chronic cavitary and Fibrosing pulmonary and pleural aspergillosis: Case series, proposed nomenclature change, and review [J].
Denning, DW ;
Riniotis, K ;
Dobrashian, R ;
Sambatakou, H .
CLINICAL INFECTIOUS DISEASES, 2003, 37 :S265-S280